SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Access Industries Holdings LLC (Last) (First) (Middle) 40 WEST 57TH ST, 28TH FL (Street) NEW YORK NY 10019 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 01/01/2022	3. Issuer Name and Ticker or Trading Symbol Gamida Cell Ltd. [ GMDA ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year) 01/11/2022
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* Access Industries Holdings LLC (Last) (First) (Middle) 40 WEST 57TH ST, 28TH FL (Street) NEW YORK NY 10019 (City) (State) (Zip)

1. Name and Address of Reporting Person* Clal Biotechnology Industries Ltd. (Last) (First) (Middle) 3 AZRIELI CENTER TRIANGLE TOWER, 45TH FLOOR, 132 MENACHEM BEGIN ST. (Street) TEL AVIV L3 6702301 (City) (State) (Zip)

1. Name and Address of Reporting Person* Bio Medical Investment (1997) Ltd. (Last) (First) (Middle) 3 AZRIELI CENTER TRIANGLE TOWER, 45TH FLOOR, 132 MENACHEM BEGIN ST. (Street) TEL AVIV L3 6702301 (City) (State) (Zip)

1. Name and Address of Reporting Person* ACCESS INDUSTRIES, LLC (Last) (First) (Middle) 40 WEST 57TH ST, 28TH FL (Street) NEW YORK NY 10019 (City) (State) (Zip)

1. Name and Address of Reporting Person* ACCESS INDUSTRIES MANAGEMENT, LLC (Last) (First) (Middle) 40 WEST 57TH ST, 28TH FL (Street) NEW YORK NY 10019 (City) (State) (Zip)

1. Name and Address of Reporting Person* Blavatnik Len (Last) (First) (Middle) 40 WEST 57TH ST, 28TH FL (Street) NEW YORK NY 10019 (City) (State) (Zip)

1. Name and Address of Reporting Person* AI Gamida Holdings LLC (Last) (First) (Middle) 40 WEST 57TH ST, 28TH FL (Street) NEW YORK NY 10019 (City) (State) (Zip)

Explanation of Responses:

Remarks:

This amendment is being filed to add Bio Medical Investment (1997) Ltd. as a reporting filer to the original Form 3 filed on January 11, 2022.

No securities are beneficially owned.

	/s/ Alejandro Moreno for Access Industries Holdings LLC	01/13/2022
	/s/ Ofer Gonen (CEO) and Assaf Segal (CFO) for Clal Biotechnology Industries Ltd.	01/13/2022
	/s/ Ofer Gonen (Director) and Assaf Segal (Director) for Bio Medical Investment (1997) Ltd.	01/13/2022
	/s/ Alejandro Moreno for Access Industries, LLC	01/13/2022
	/s/ Alejandro Moreno for Access Industries Management, LLC	01/13/2022
	/s/ Alejandro Moreno, as Attorney-in-Fact for Mr. Blavatnik	01/13/2022
	/s/ Alejandro Moreno for AI Gamida Holdings LLC	01/13/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.